GISAID’s Role in Pandemic Response-Reference-Cited by-同舟云学术

GISAID’s Role in Pandemic Response

Published:2021 Issue:49 Volume:3 Page:1049-1051
ISSN:2096-7071
Container-title:China CDC Weekly
language:en
Short-container-title:

Author:

Khare Shruti, ,Gurry Céline,Freitas Lucas,B Schultz Mark,Bach Gunter,Diallo Amadou,Akite Nancy,Ho Joses,TC Lee Raphael,Yeo Winston,Core Curation Team GISAID,Maurer-Stroh Sebastian, , , , , , , , , ,

Publisher

Chinese Center for Disease Control and Prevention

Subject

Applied Mathematics,General Mathematics

Link

http://weekly.chinacdc.cn/en/article/pdf/preview/10.46234/ccdcw2021.255

Reference7 articles.

1. Tan WJ, Zhao X, Ma XJ, Wang WL, Niu PH, Xu WB, et al. A novel coronavirus genome identified in a cluster of pneumonia cases—Wuhan, China 2019−2020. China CDC Wkly 2020;2(4):61 − 2. http://dx.doi.org/10.46234/ccdcw2020.017.

2. Elbe S, Buckland-Merrett G. Data, disease and diplomacy: GISAID’s innovative contribution to global health. Glob Chall 2017;1(1):33 − 46. http://dx.doi.org/10.1002/GCH2.1018.

3. Shu YL, McCauley J. GISAID: global initiative on sharing all influenza data–from vision to reality. Eurosurveillance 2017;22(13):30494. http://dx.doi.org/10.2807/1560-7917.ES.2017.22.13.30494.

4. Swaminathan S. The WHO's chief scientist on a year of loss and learning. Nature 2020;588(7839):583 − 5. http://dx.doi.org/10.1038/d41586-020-03556-y.

5. Bohn MK, Mancini N, Loh TP, Wang CB, Grimmler M, Gramegna M, et al. IFCC interim guidelines on molecular testing of SARS-CoV-2 infection. Clin Chem Lab Med 2020;58(12):1993 − 2000. http://dx.doi.org/10.1515/cclm-2020-1412.

Cited by 720 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Classification of a Massive Number of Viral Genomes and Estimation of Time of Most Recent Common Ancestor (tMRCA) of SARS-CoV-2 Using Phylodynamic Analsysis;BIO-PROTOCOL;2025

2. An outbreak of SARS-CoV-2 omicron variant and deaths of three lions in a zoo;One Health;2024-12

3. Highly specific SARS-CoV-2 main protease (Mpro) mutations against the clinical antiviral ensitrelvir selected in a safe, VSV-based system;Antiviral Research;2024-11

4. Computational Analysis of the Accumulation of Mutations in Therapeutically Important RNA Viral Proteins During Pandemics with Special Emphasis on SARS-CoV-2;Journal of Molecular Biology;2024-10

5. Exploring the binding dynamics of covalent inhibitors within active site of PLpro in SARS-CoV-2;Computational Biology and Chemistry;2024-10